Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,654 | -2,601 | -21,801 | -17,755 | -135,094 |
| Depreciation Amortization | 168 | 82 | 339 | 256 | 1,762 |
| Accounts receivable | 179 | 202 | -264 | -138 | -1,729 |
| Accounts payable and accrued liabilities | -631 | 6 | -448 | 377 | 6,912 |
| Other Working Capital | -1,354 | -475 | 165 | 562 | -92 |
| Other Operating Activity | 1,599 | 238 | 4,785 | 2,863 | 17,692 |
| Operating Cash Flow | $-5,692 | $-2,550 | $-17,225 | $-13,835 | $-110,549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -3 | -1 | -1 | N/A |
| Sale Of Investment | N/A | N/A | 4 | 4 | N/A |
| Investing Cash Flow | $-6 | $-3 | $3 | $3 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,367 | 1,273 | 4,760 | 4,691 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -223 | -141 |
| Other Financing Activity | -235 | -162 | -1,509 | -1,081 | -9,331 |
| Financing Cash Flow | $6,131 | $1,111 | $3,251 | $3,386 | $-9,472 |
| Exchange Rate Effect | -198 | -31 | -206 | 30 | -854 |
| Beginning Cash Position | 7,739 | 7,519 | 21,466 | 21,204 | 212,141 |
| End Cash Position | 7,975 | 6,046 | 7,290 | 10,789 | 91,266 |
| Net Cash Flow | $236 | $-1,472 | $-14,176 | $-10,415 | $-120,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,692 | -2,550 | -17,225 | -13,835 | -110,549 |
| Capital Expenditure | -6 | -3 | -1 | -1 | N/A |
| Free Cash Flow | -5,698 | -2,553 | -17,225 | -13,835 | -110,549 |